NeuroPace (NPCE) Non-Current Debt (2020 - 2026)
NeuroPace (NPCE) posted quarterly Non-Current Debt of $59.0 million for Q1 2026, down 1.28% year-over-year from $59.8 million in Q1 2025, and little changed quarter-over-quarter from $58.9 million in Q4 2025.
NeuroPace (NPCE) Non-Current Debt (2020 - 2026) Analysis & Trends
NeuroPace's Non-Current Debt history runs 7 years deep, the most recent figure standing at $59.0 million for Q1 2026.
- In Q1 2026, Non-Current Debt fell 1.28% year-over-year to $59.0 million; the TTM figure through Mar 2026 stood at $59.0 million (down 1.28% YoY), while the FY2025 annual figure was $58.9 million, down 1.08% from the prior year.
- Non-Current Debt for Q1 2026 stood at $59.0 million, roughly flat from $58.9 million in the prior quarter.
- The five-year high for Non-Current Debt was $59.8 million in Q1 2025, with the low at $50.1 million in Q1 2022.
- The 5-year median for Non-Current Debt is $58.0 million (2024), against an average of $56.4 million.
- The sharpest annual moves came in 2024 and 2026: Non-Current Debt increased 7.76% in 2024, then decreased 1.28% in 2026.
- NeuroPace's Non-Current Debt stood at $52.9 million in 2022, then climbed by 7.64% to $57.0 million in 2023, then climbed by 4.51% to $59.5 million in 2024, then slipped by 1.08% to $58.9 million in 2025, then advanced by 0.23% to $59.0 million in 2026.
- Business Quant data shows NPCE's Non-Current Debt at $59.0 million in Q1 2026, $58.9 million in Q4 2025, and $58.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.65 Bn |
| 10 | NeuroPace | 479.51 Mn | 427.81 Mn | 18.91 Mn | 59.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.01 Mn |
| Mar 31, 2026 | 59.02 Mn |
| Dec 31, 2025 | 58.88 Mn |
| Sep 30, 2025 | 58.75 Mn |
| Jun 30, 2025 | 58.62 Mn |
| Mar 31, 2025 | 59.79 Mn |
| Dec 31, 2024 | 59.53 Mn |
| Sep 30, 2024 | 59.27 Mn |
| Jun 30, 2024 | 59.02 Mn |
| Mar 31, 2024 | 58.04 Mn |
| Dec 31, 2023 | 56.95 Mn |
| Sep 30, 2023 | 55.89 Mn |
| Jun 30, 2023 | 54.85 Mn |
| Mar 31, 2023 | 53.86 Mn |
| Dec 31, 2022 | 52.91 Mn |
| Sep 30, 2022 | 51.95 Mn |
| Jun 30, 2022 | 51.02 Mn |
| Mar 31, 2022 | 50.12 Mn |
| Dec 31, 2021 | 49.85 Mn |
| Sep 30, 2021 | 49.58 Mn |